Plasma p‐tau181 is associated with brain amyloid deposition and predicts MCI conversion to AD
Yung‐Shuan Lin · 2025
Read Plasma p‐tau181 is associated with brain amyloid deposition and predicts MCI conversion to AD by Yung‐Shuan Lin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715111.txt.
Description
A blood test for a changed tau protein may help spot Alzheimer's disease and warn of decline, Yung-Shuan Lin reports in a 2025 study. Lin studied ninety-eight adults who had brain scans for amyloid plaques, plus a smaller group with mild memory loss who were followed over time. Blood levels of the protein were measured with a sensitive lab method.
Plaques were found in about half the adults with dementia and in a small share of those without. Blood protein levels tracked plaque status and memory state in the tests. In the follow-up group, starting levels helped forecast who moved from mild loss to full disease. The author argues the cheap blood test could aid early care planning.
Catalog record
| CREATOR | Yung‐Shuan Lin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |